Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07976016 formulation comparison in healthy volunteers
NCT06670170Phase 1Completed
- Sponsor
- Pfizer
- Start
- Nov 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of PF-07976016 (2 arms), sponsored by Pfizer. Primary endpoints: Area Under the Curve - infinity at 168 hours and Area Under the Curve - last at 168 hours. Started Nov 2024; status: completed.
02
Drugs
PF-07976016
Beyond the preview
Go deeper on NCT06670170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06670170.